BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Phenomix Corporation 

5871 Oberlin Drive
Suite 200
San Diego  California  92121  U.S.A.
Phone: 858-731-5200 Fax: 858-731-5225


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Phenomix Corporation, Former Highflying Diabetes Drugmaker, Shuts Down After Forest Laboratories, Inc. (FRX) Walks 10/26/2010 8:10:09 AM    More...
Phenomix Corporation Announces Positive Results from a Phase 3 Study of Dutogliptin in Type 2 Diabetes Mellitus 4/20/2010 6:21:02 AM    More...
Phenomix Corporation Grants Chiesi Farmaceutici SpA European Rights to Dutogliptin for Diabetes in Deal Worth Up to $191 Million 12/2/2009 9:03:47 AM    More...
Phenomix Corporation Implements etrials’ Trial Intelligence EDC to Improve Data Quality, Integrate Data in Real-time 3/31/2009 10:25:21 AM    More...
Phenomix Corporation Initiates Phase 1a Clinical Trial of Hepatitis C Protease Inhibitor PHX1766 10/28/2008 8:41:17 AM    More...
Forest Laboratories, Inc. (FRX) (JOBS) and Phenomix Corporation in $340 Million Diabetes Deal 10/23/2008 6:38:42 AM    More...
Phenomix Corporation Announces PHX1149 Phase 2b Clinical Trial Results for Type 2 Diabetes 5/19/2008 10:04:08 AM    More...
Phenomix Corporation Files for $86.25 Million IPO 1/28/2008 7:04:31 AM    More...
Phenomix Corporation Hires John Crawford as Chief Financial Officer and Appoints Arlene Morris to Board of Directors 10/17/2007 11:03:22 AM    More...
Phenomix Corporation Initiates Phase 2b Clinical Trial of PHX1149 for Type 2 Diabetes; Will Present PHX1149 Data at EASD 9/11/2007 9:54:36 AM    More...
123